Public Market Listing
IPHEuronext Paris
Live quotes, historical charts, and market capitalization for Innate Pharma are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(3 total)
3Total Assets
0Approved
1Phase 3 / Filed
2Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | NKG2AMonoclonal antibody | Non-Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma | |
| Phase 1 | Nectin-4Antibody–drug conjugate | Non-Small Cell Lung Cancer | |
| Preclinical / Unstaged | —Monoclonal antibody | Cutaneous T-Cell Lymphoma |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.